1/30/2008
Bright ideas corner cash at venture capital forum
12/19/2007
Presenters At Upcoming Venture Capital Conference Announced
4/23/2007
“Intezyne Technologies,” Greater Tampa Chamber of Commerce
1/25/2007
Biotech Building in Plans for USF
9/21/2004
“Biotech Firm Settles on USF Incubator,” Tampa Bay Business Journal


Intezyne Technologies is led by its Management team including CEO Habib Skaff and CSO Kevin Sill. In order to further strengthen Intezyne's executive team and guide the Company during its growth and development, an experienced Board of Directors and Scientific Advisory Board have been assembled. The Board of Directors is currently comprised of the two members of the Management team and four outside members with expertise in the pharmaceutical and biotechnology industry, IP establishment and protection, and business development. In addition to the Board of Directors, a Scientific Advisory Board has been established and includes individuals with expertise in a wide range of scientific disciplines. The members are leaders in their respective fields and aid Intezyne in its continued growth and development in its scientific endeavors.

PEOPLE

Habib Skaff, Ph.D.
Chief Executive Officer
Kevin Sill, Ph.D.
Chief Science Officer


Drug Delivery System | Drug Delivery
COMPANY PROFILE | OUR TECHNOLOGY | NEWS | CONTACT US | INTEZYNE HOME
INTEZYNE technologies 2007